, Le pharmacien délivre les analogues de la GnRH dès présentation de l'ordonnance car le jour d'utilisation n'est pas connu à l'avance et le médicament peut manquer

, Ces injections, lorsqu'elles sont journalières, s'effectuent en même temps que celles des gonadotrophines mais sur des sites d'injection différents et les deux spécialités ne doivent pas être mélangées dans la même seringue

, ovulation ne doit pas dépasser 30 heures, au risque qu'une ovulation prématurée se produise et remette en cause le protocole. Dans le cas ou l'injection de l'analogue se fait dans la matinée, il faut donc également l'injecter le matin le jour de l'injection de l'inducteur de l'ovulation. Si c'est le soir, comme cela est fait dans la grande majorité des cas

, Les gonadotrophines humaines s'injectent le soir à heures régulières pour permettre de faire les contrôles sanguins le matin et d'ajuster le soir si besoin le dosage du traitement

. Bibliographie,

N. Marieb-elaine, Anatomie et Physiologie Humaine. 6 ème édition-Paris, 2005.

F. Pellestor, Histologie des appareils génitaux féminins

, MI5/Reproduction/MI5_reproduction_histologie_fem ale.pdf (3) Faure A-K. Ovogénèse, folliculogénèse, fécondation

J. M. Plouchart and M. Lopes, Biologie de la reproduction cahier 1, Analyse du sperme en première intention, 2016.

R. M. Sharpe, H. M. Fraser, and M. F. Brougham, Role of the neonatal period of pituitarytesticular activity in germ cell proliferation and differenciation in the mate testis, Hum Reprod, vol.18, pp.2110-2117, 2003.

Y. Clermont, Kinetics of spermatogenesis in mammals :seminiferous epithelium cycle and spermatogonial renewal, Physiol Rev, vol.52, pp.198-235, 1972.

D. D. Mruk and C. Y. Cheng, The mammalian blood-testis barrier :its biology and regulation

, Endocr Rev, vol.36, pp.594-91, 2015.

K. Caires, J. Broady, and D. Mclean, Maintaining the male germline : regulation of spermatogonial stem cells, J Endocrinol, vol.205, pp.133-178, 2010.

D. M. Kretser, K. L. Loveland, and A. Meinhardt, Hum Reprod, vol.13, pp.1-8, 1998.

N. Sofikitis, N. Giotitas, and P. Tsounapil, Hormonal regulation of spermatogenesis and spermiogenesis, J Steroid Biochem Mol Biol, vol.109, pp.323-353, 2008.

, Guide d'initiation aux techniques de l'Assistance Médicale à la procréation (AMP)

M. Brochure, , 2013.

, Le Moniteur des Pharmacies-Formation, L'assistance médicale à la procréation. Cahier 2 n°2908 Décembre, 2011.

A. M. Chiarelli, L. D. Marret, and G. A. Darlington, Pregnancy outcomes in females after treatment for chilhooh cancer, Epidemiology, vol.11, pp.161-167, 2000.

, Conséquences des traitements des cancers et prévention de la fertilité Etat des connaissances et propositions. Agence de la Biomedecine, Brochure. (15) Institut National du cancer, Comprendre la chimiothérapie, 2008.

J. R. Barton, A. J. Sibai, and N. B. Istwan, Spontaneously conceived pregnancy after 40 : influence of age and obesity on outcome, Am J Perinatal, vol.31, pp.795-803, 2014.

R. G. Radin, E. E. Hatch, and K. J. Rothman, Active and passive smoking and fecundability in Danish pregnancy planners, Fertil Steril, vol.102, pp.183-91, 2014.

E. J. Elliot, Fetal alcohol spectrum disorders in Australia-the future is prevention, Public Health Res Pract, vol.25, 2015.

C. Ferte-delbende, C. , S. Barriere, P. Dewailly, and D. , Evaluation of the ovarian reserve, J Gynecol Obstet Biol Reprod (Paris), vol.39, pp.27-33, 2010.

F. J. Broekmans, J. Kwee, and D. J. Hendricks, A systematic review of testis predicting ovarian reserve and IVF outcome, Reprod Update, vol.12, pp.685-718, 2006.

A. Torre, . Poulyjl, B. Wainer, C. Yazbeck, L. Tohic et al., Anatomic evaluation of the female of the infertile couple, J Gynecol Obstet Biol Reprod (Paris), vol.39, issue.22, pp.424-431, 2010.

J. Pundir, V. Pundir, and K. Omanwa, Hysteroscopy prior to the first IVF cycle : a systematic rewiew and meta-analysis, Reprod Biomed Online, vol.28, pp.151-61, 2014.

S. Belloc, A. Hazout, and A. Zini, How to overcome male infertility after 40 : influence of paternal age on fertility, Maturitas, vol.78, pp.22-31, 2014.

M. T. Zenges, Smoking and reproduction : gene damage to human gametes and embryos

, Hum Reprod Update, vol.6, pp.122-153, 2000.

K. R. Muthusami and P. Chinnaswamy, Effect of chronic alcoholism on male fertility hormones and semen quality, Fertil Steril, vol.84, pp.919-943, 2005.

, Exploration de la fonction de reproduction. Versant masculin. Cahier de formation de biologie médicale, p.42, 2009.

T. Freour, A. Delvigne, and . Barrierep, Evaluation of the male of the infertile couple, J Gynecol Obstet Biol Reprod (Paris), vol.39, pp.45-52, 2010.

T. Ammar, P. S. Sidhu, and C. J. Wilkins, Male Infertility : The role of imaging in diagnostis and management, Brit J Radiodol, vol.85, pp.559-68, 2012.

F. Tuttelmann, J. Gromoll, and S. Kliesch, Genetics in male infertility, Urologe, vol.47, pp.1561-1568, 2008.

F. Tuttelmann and J. Gromoll, Novel genetic aspects of klinefelter's syndrome, Mol Hum Reprod, vol.16, pp.386-95, 2010.

J. M. Plouchart and M. Lopes, Fecondation in vitro et techniques associées, 2016.

M. Kp, S. G. Hillier, and A. M. Van-den-boogaard, Follicular developpement during the lueal phase of the human menstrual cycle, J Clin Endocrinol Metab, vol.56, pp.1022-1053, 1983.

R. Fanchin, J. M. Ayoubi, and C. Righini, Uterine contractility decreases at the time of blastocyst transferts, Hum Reprod, vol.16, pp.1115-1124, 2001.

A. Capalbo, S. Bono, and L. Spizzichino, Sequential comprehensive chromosome analysis on polar bodies, blastomeres and trophoblast : insights into female meiotic errors and chromosomal segregation in the preimplantation window of embryo development, Hum Reprod, vol.28, pp.509-527, 2013.

S. Neveu, B. Hedon, and J. Bringer, Ovarian stimulation by a combination of a gonadotropin-releasing hormone agonist and gonadotropin for in viro fertilization, Fertil Steril, vol.47, pp.639-682, 1987.

D. R. Meldrum, GnRH agonists as adjuncts for in vitro fertilization, Obstet Gynecol Surv, vol.44, pp.314-320, 1989.

N. A. Klein, D. E. Battaglia, and V. Y. Fujimoto, Reproductive aging : accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women, J Clin Endocrinol Metab, vol.81, pp.1038-1083, 1996.

G. S. Jones, M. De-moraes-ruehsen, and A. J. Johanson, Elucidation of normal ovarian physiology by exogenous gonadotropin stimulation following steroid pituitary suppression

, Fertil Steril, vol.20, pp.14-34, 1969.

P. Pujol-amat, J. M. Urgell-roca, and M. Maroquez-ramirez, The ovarian response to gonadotropihins after administration of an oral contraceptive, J Obstet Gynaecol Br Commonw, vol.78, pp.261-266, 1971.

Y. Gonen, W. Jacobson, and R. F. Casper, Gonadotropin suppression with oral contracptives before in vitro fertilization, Fertil Steril, vol.53, pp.282-289, 1990.

C. Y. Andersen and K. V. Andersen, Improving the luteal phase after ovarian stimulation : reviewing new options, Reproductive Biomedecine Online, vol.28, pp.552-561, 2014.

J. Balasch, M. Creus, and F. Fabregues, Hormonal profiles in successful implantation in IVF-ET after combined GnRH agonist/ gonadotropin treatment for superovulation and hCG luteal support, Gynecol Endocrinol, vol.9, pp.51-59, 1995.

T. Simoncini, A. Caruso, and M. S. Giretti, Effects of dydrogesterone and of its stable metabolite, 20-alpha-dihydrogesterone, on nitric oxide synthesis in human endothelial cells

, Fertil Steril, vol.86, pp.1235-1277, 2006.

S. M. Sladek, R. R. Magness, and K. P. Comrad, Nitric oxide and pregnancy, Am J Physiol, vol.272, pp.441-63, 1997.

D. Ziegler, D. , L. Scharer, E. Bouchard, and P. , Non-oral administration of progesterone : experiences and possibilities of the transvaginal route, Schweiz Rundsch Med Prax, vol.84, pp.127-160, 1995.

I. E. Messinis, T. Bergh, and L. Wide, The importance of human chorionic gonadotropin support of the corpus luteum during human gonadotropin therapy in women with anovulatory infertility, Fertil Steril, vol.50, pp.31-36, 1988.

D. Vital-durand, L. Jeune, and C. , Guide pratique des médicaments ; Dorosz, 32 ème édition

. Maloine, , 2013.

, Le moniteur des pharmacies-Actualité. Nouveaux médicaments-Ovaleap. Cahier, vol.1, p.3130, 2016.

, Le moniteur des pharmacies-Actualité. Nouveaux médicaments-Bemfola. Cahier 1, n°3082, 2015.

, Le moniteur des pharmacies-Actualité. Nouveaux médicaments-Elonva. Cahier 1, n°3025, 2014. (53) Le moniteur des pharmacies-Actualité, Nouveaux médicaments-Fertistartkit. Cahier, vol.1, p.3132, 2016.

E. Cicinelli, D. De-ziegler, and C. Bulletti, Direct transport of progesterone from vagina to uterus, Obstet Gynecol, vol.95, pp.403-409, 2000.

M. Van-der-linden, K. Buckingham, and C. Farquhar, Luteal phase support for assisted reproduction cycles, Cochrane Database Syst Rev, vol.10, 2011.

M. Connell, J. Szatkowski, and N. Terry, Timing luteal support in assisted reproductive technology : a systematic rewiew, Fertil Steril, vol.103, pp.939-985, 2015.

, Le moniteur des pharmacies-Actualité. Nouveaux médicaments-Crinone. Cahier, vol.1, p.3099, 2015.

L. Nardo, T. El-toukhy, and J. Stewart, British Fertility Society Policy and Practice Committee : adjuvants in IVF : evidence for good clinical practice, Human Fertil (Camb), vol.18, pp.2-15, 2014.

M. A. Akhtar, S. Sur, and N. Raine-fenning, Heparin for assisted reproduction, Cochrane Database Syst Rev, vol.8, 2013.

L. O. Tso, M. F. Costello, and L. E. Albuquerque, Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome, Cochrane Database Syst Rev, vol.11, 2014.

M. Ben-maamar, Ibuprofen results in alterations of human fetal testis development, Scientific Report, vol.7, p.4418, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01517095